What is Nature's Sunshine Products' operating income?

Nature's Sunshine Products' total operating income in 2024 was $20.10 million, based on the following breakdown: Total Gross Profit: $324.69 million Total Operating Expenses: $304.59 million

Nature's Sunshine Products (NATR) Financials

$21.47 0.00 (0.00%)

Closing price 07/2/2026 04:00 PM Eastern

Extended Trading

$21.68 +0.21 (+0.95%)

As of 07:02 AM Eastern

Compare

Annual Income Statements for Nature's Sunshine Products

This table shows Nature's Sunshine Products' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	10	15	2.14	-13	-0.85	6.77	21	29	-0.39	15	7.70
Consolidated Net Income / (Loss)	9.80	14	0.68	-14	-1.20	6.93	23	30	0.55	16	7.89
Net Income / (Loss) Continuing Operations	20	12	0.68	-14	-1.20	6.93	23	30	0.55	16	7.89
Total Pre-Tax Income	19	13	9.27	3.22	3.20	16	23	32	15	20	18
Total Operating Income	19	14	10	1.39	5.35	16	21	35	16	19	20
Total Gross Profit	275	239	250	251	269	268	284	329	300	321	325
Total Revenue	366	325	341	342	365	362	385	444	422	445	454
Operating Revenue	366	325	341	342	365	362	385	444	422	445	454
Total Cost of Revenue	92	85	91	91	96	94	101	115	122	124	130
Operating Cost of Revenue	92	85	91	91	96	94	101	115	122	124	130
Total Operating Expenses	256	225	240	250	264	252	262	294	284	302	305
Selling, General & Admin Expense	120	108	120	130	138	129	131	154	153	167	164
Other Operating Expenses / (Income)	136	118	120	120	125	123	131	140	130	135	141
Total Other Income / (Expense), net	-0.03	-0.59	-0.77	1.84	-2.15	-0.48	1.34	-2.85	-1.04	1.45	-1.67
Interest Expense	0.19	0.13	0.02	0.29	0.39	0.04	0.10	0.25	0.25	0.07	0.15
Interest & Investment Income	-	-	-	-	-	0.26	0.17	0.47	0.12	0.55	0.18
Other Income / (Expense), net	0.15	-0.46	-0.76	2.12	-1.76	-0.70	1.27	-3.06	-0.92	0.97	-1.70
Income Tax Expense	-0.74	1.74	8.59	17	4.40	8.71	-0.14	1.62	15	3.79	11
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.22	-1.03	-1.46	-0.88	-0.35	0.16	1.62	1.35	0.94	1.34	0.20
Basic Earnings per Share	$0.58	$0.79	$0.11	($0.69)	($0.04)	$0.35	$1.09	$1.45	($0.02)	$0.79	$0.41
Weighted Average Basic Shares Outstanding	17.11M	18.66M	18.73M	18.88M	19.12M	19.31M	19.54M	19.86M	19.33M	19.07M	18.62M
Diluted Earnings per Share	$0.56	$0.77	$0.11	($0.69)	($0.04)	$0.34	$1.07	$1.42	($0.02)	$0.77	$0.40
Weighted Average Diluted Shares Outstanding	17.64M	19.18M	19.06M	18.88M	19.12M	19.66M	19.97M	20.33M	19.33M	19.47M	19.09M
Weighted Average Basic & Diluted Shares Outstanding	17.30M	18.60M	19.40M	19.02M	19.27M	19.47M	19.80M	19.45M	19.06M	18.82M	18.48M

This table shows Nature's Sunshine Products' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	2.83	8.96	2.32	1.35	4.35	-0.32	4.75	5.33	5.33	5.12
Consolidated Net Income / (Loss)	3.14	9.34	2.49	1.49	4.65	-0.73	4.88	5.52	5.54	5.12
Net Income / (Loss) Continuing Operations	3.14	9.34	2.49	1.49	4.65	-0.73	4.88	5.52	5.54	5.12
Total Pre-Tax Income	4.91	7.66	4.66	4.42	7.90	1.45	7.11	7.54	9.67	8.16
Total Operating Income	5.83	5.71	4.62	5.64	5.28	4.55	6.17	4.27	8.98	9.55
Total Gross Profit	81	78	79	79	82	85	82	82	94	90
Total Revenue	111	109	111	111	115	118	113	115	128	123
Operating Revenue	111	109	111	111	115	118	113	115	128	123
Total Cost of Revenue	30	31	32	32	33	33	32	32	34	33
Operating Cost of Revenue	30	31	32	32	33	33	32	32	34	33
Total Operating Expenses	75	73	74	73	76	81	75	78	85	80
Selling, General & Admin Expense	41	40	41	39	41	44	41	44	46	44
Other Operating Expenses / (Income)	34	33	34	35	36	37	35	34	39	37
Total Other Income / (Expense), net	-0.93	1.95	0.03	-1.21	2.62	-3.10	0.94	3.27	0.70	-1.39
Interest Expense	-	-	0.01	0.10	0.03	-	0.02	0.02	0.03	0.04
Interest & Investment Income	-	-	0.06	0.41	-0.01	-	0.21	0.27	0.05	0.07
Other Income / (Expense), net	-0.93	1.47	-0.02	-1.52	2.65	-3.13	0.75	3.03	0.67	-1.43
Income Tax Expense	1.76	-1.68	2.17	2.94	3.25	2.18	2.23	2.03	4.14	3.04
Net Income / (Loss) Attributable to Noncontrolling Interest	0.31	0.38	0.17	0.14	0.30	-0.41	0.14	0.19	0.20	0.00
Basic Earnings per Share	$0.15	$0.46	$0.12	$0.07	$0.23	($0.01)	$0.26	$0.29	$0.30	$0.29
Weighted Average Basic Shares Outstanding	19.13M	19.07M	18.83M	18.65M	18.51M	18.62M	18.49M	18.41M	17.64M	17.52M
Diluted Earnings per Share	$0.15	$0.46	$0.12	$0.07	$0.23	($0.02)	$0.25	$0.28	$0.30	$0.29
Weighted Average Diluted Shares Outstanding	19.49M	19.47M	19.22M	19.12M	18.89M	19.09M	18.85M	18.97M	18.03M	17.93M
Weighted Average Basic & Diluted Shares Outstanding	19.08M	18.82M	18.73M	18.51M	18.48M	18.48M	18.35M	17.64M	17.50M	17.58M

This table details how cash moves in and out of Nature's Sunshine Products' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	-19	-17	-9.14	11	7.73	3.38	38	-5.89	-26	22	2.33
Net Cash From Operating Activities	14	10	3.42	11	22	8.55	38	35	0.71	41	25
Net Cash From Continuing Operating Activities	14	10	3.42	11	22	8.55	38	35	0.71	41	25
Net Income / (Loss) Continuing Operations	9.80	14	0.68	-14	-1.20	6.93	23	30	0.55	16	7.89
Consolidated Net Income / (Loss)	9.80	14	0.68	-14	-1.20	6.93	23	30	0.55	16	7.89
Depreciation Expense	4.41	4.53	4.81	8.63	9.81	11	11	11	11	12	14
Amortization Expense	0.00	-	-	-	-	-	-	-	-	4.42	5.42
Non-Cash Adjustments To Reconcile Net Income	4.40	1.84	6.37	2.17	3.15	6.86	7.60	16	9.52	5.17	6.33
Changes in Operating Assets and Liabilities, net	-4.43	-9.86	-8.44	14	10	-16	-3.64	-23	-20	3.41	-8.56
Net Cash From Investing Activities	-27	-19	-12	-3.20	0.21	-5.10	-4.91	-6.61	-7.63	-10	-11
Net Cash From Continuing Investing Activities	-27	-19	-12	-3.20	0.21	-5.10	-4.91	-6.61	-7.63	-10	-11
Purchase of Property, Plant & Equipment	-26	-23	-11	-5.50	-4.83	-5.10	-4.91	-6.67	-7.63	-10	-11
Net Cash From Financing Activities	-5.08	-7.58	-0.29	1.57	-12	-0.06	3.88	-32	-16	-7.96	-9.91
Net Cash From Continuing Financing Activities	-5.08	-7.58	-0.29	1.57	-12	-0.06	3.88	-32	-16	-7.96	-9.91
Repayment of Debt	-12	0.00	0.00	-16	-82	-2.06	-5.69	-2.20	-47	-17	-41
Repurchase of Common Equity	-7.46	-6.65	-	-	-	-	0.00	-7.43	-14	-6.40	-8.86
Issuance of Debt	0.00	2.70	7.22	20	69	2.06	9.10	0.00	45	16	41
Other Financing Activities, net	5.08	3.86	0.00	-0.35	-0.01	-0.06	0.47	-2.24	-1.13	-0.39	-1.05
Effect of Exchange Rate Changes	-0.98	-1.27	-0.74	1.73	-	-	1.81	-	-2.99	-0.45	-2.10
Cash Interest Paid	0.17	0.06	0.25	0.26	0.40	0.06	0.09	0.20	0.26	0.54	0.12
Cash Income Taxes Paid	6.45	9.78	3.59	4.60	3.54	6.86	4.83	6.22	5.61	9.26	15

This table details how cash moves in and out of Nature's Sunshine Products' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Net Change in Cash & Equivalents	7.07	6.34	-4.60	-9.08	10	6.00	1.79	-5.14	14	-6.31
Net Cash From Operating Activities	14	9.60	2.19	1.31	9.62	12	2.61	4.34	18	-1.85
Net Cash From Continuing Operating Activities	14	9.60	2.19	1.31	9.62	12	2.61	4.34	18	-1.85
Net Income / (Loss) Continuing Operations	3.14	9.34	2.49	1.49	4.65	-0.73	4.88	5.52	5.54	5.12
Consolidated Net Income / (Loss)	3.14	9.34	2.49	1.49	4.65	-0.73	4.88	5.52	5.54	5.12
Depreciation Expense	3.13	3.05	3.16	3.50	3.54	4.02	3.50	3.50	3.54	3.22
Amortization Expense	1.19	1.13	1.20	2.10	1.09	1.03	1.48	1.20	1.12	1.01
Non-Cash Adjustments To Reconcile Net Income	1.51	-1.47	1.23	2.65	-1.11	3.55	2.51	-2.28	3.52	6.10
Changes in Operating Assets and Liabilities, net	5.40	-2.46	-5.89	-8.44	1.46	4.31	-9.76	-3.59	4.76	-17
Net Cash From Investing Activities	-4.48	-1.25	-3.69	-3.35	-1.74	-2.20	-1.11	-1.35	-1.68	-2.48
Net Cash From Continuing Investing Activities	-4.48	-1.25	-3.69	-3.35	-1.74	-2.20	-1.11	-1.35	-1.68	-2.48
Purchase of Property, Plant & Equipment	-4.48	-1.25	-3.69	-3.35	-1.74	-2.20	-1.11	-1.35	-1.68	-2.48
Net Cash From Financing Activities	-1.55	-4.59	0.11	-8.42	-1.02	-0.58	-0.73	-12	-2.40	-1.58
Net Cash From Continuing Financing Activities	-1.55	-4.59	0.11	-8.42	-1.02	-0.58	-0.73	-12	-2.40	-1.58
Repayment of Debt	-0.32	-3.01	-2.70	-32	-5.96	-0.82	-0.74	-1.09	-	-12
Repurchase of Common Equity	-1.31	-4.17	-1.85	-5.88	-0.71	-0.42	-0.48	-12	-2.02	-0.50
Issuance of Debt	-	2.79	4.81	29	5.96	0.82	0.74	1.09	-	12
Other Financing Activities, net	0.08	-0.21	-0.15	-0.43	-0.31	-0.15	-0.26	-0.24	-0.37	-1.08
Effect of Exchange Rate Changes	-1.26	2.58	-3.21	1.39	3.14	-3.42	1.02	3.99	-0.19	-0.41
Cash Interest Paid	0.01	0.42	0.01	0.10	0.03	-0.02	0.02	0.03	0.03	0.04
Cash Income Taxes Paid	2.33	1.80	1.38	6.76	1.64	5.01	1.88	4.34	1.49	2.38

This table presents Nature's Sunshine Products' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	201	206	195	193	213	249	259	230	250	241	261
Total Current Assets	102	95	103	107	113	154	165	150	166	161	179
Cash & Equivalents	41	32	43	51	54	92	86	60	82	85	94
Accounts Receivable	7.70	7.74	8.89	7.75	7.32	7.38	8.87	14	8.83	9.48	8.60
Inventories, net	38	48	44	42	47	48	61	68	67	59	68
Prepaid Expenses	7.11	4.59	5.67	6.39	5.09	6.94	8.76	7.42	7.72	6.96	8.04
Plant, Property, & Equipment, net	69	73	69	64	60	54	51	46	45	40	33
Total Noncurrent Assets	30	38	24	22	41	41	43	34	39	41	49
Long-Term Investments	-	-	-	-	-	0.99	0.96	0.70	0.75	0.92	1.13
Noncurrent Deferred & Refundable Income Taxes	17	22	8.28	9.06	4.90	8.69	14	6.86	15	18	20
Other Noncurrent Operating Assets	12	15	15	12	36	31	29	27	23	22	28
Total Liabilities & Shareholders' Equity	201	206	195	193	213	249	259	230	250	241	261
Total Liabilities	64	73	75	72	84	92	97	83	90	80	100
Total Current Liabilities	53	63	54	67	58	70	77	66	77	66	79
Accounts Payable	6.34	5.31	4.22	5.22	4.41	6.49	9.70	6.35	7.91	8.91	8.02
Accrued Expenses	39	41	44	55	44	51	55	47	56	46	57
Current Deferred Revenue	4.16	3.67	3.35	1.20	1.27	2.09	3.69	2.26	1.79	2.77	5.84
Current Deferred & Payable Income Tax Liabilities	1.30	3.48	1.83	3.38	1.39	2.39	2.65	4.12	6.42	4.12	4.70
Other Current Liabilities	-	-	-	-	4.94	4.99	4.35	4.27	4.55	3.93	3.27
Total Noncurrent Liabilities	11	10	22	5.76	26	23	21	17	13	14	21
Noncurrent Deferred & Payable Income Tax Liabilities	7.81	6.76	5.40	3.75	3.15	1.48	1.57	1.65	1.71	1.64	1.38
Noncurrent Employee Benefit Liabilities	1.04	1.39	1.98	1.31	1.15	0.99	0.96	0.70	0.75	0.92	1.13
Other Noncurrent Operating Liabilities	2.27	1.99	1.24	0.71	21	18	17	15	11	12	19
Total Equity & Noncontrolling Interests	136	132	120	121	129	157	161	147	160	161	162
Total Preferred & Common Equity	134	131	119	121	129	155	158	143	154	155	162
Total Common Equity	134	131	119	121	129	155	158	143	154	155	162
Common Stock	127	130	132	134	136	139	133	122	120	115	102
Retained Earnings	18	13	-2.07	-2.07	4.69	26	35	35	50	57	77
Accumulated Other Comprehensive Income / (Loss)	-11	-11	-10	-11	-11	-9.96	-10	-13	-15	-17	-18

This table presents Nature's Sunshine Products' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	240	247	236	245	253	255	265	261
Total Current Assets	160	160	152	164	171	172	186	179
Cash & Equivalents	76	78	69	79	86	81	96	88
Accounts Receivable	9.49	9.69	11	11	11	13	15	13
Inventories, net	66	63	62	62	65	69	67	67
Prepaid Expenses	8.41	10	9.75	11	7.96	8.14	8.08	11
Plant, Property, & Equipment, net	46	45	45	42	38	36	34	31
Total Noncurrent Assets	33	42	39	40	44	47	45	51
Long-Term Investments	0.69	0.80	0.89	0.89	0.94	1.04	1.11	1.28
Noncurrent Deferred & Refundable Income Taxes	9.50	15	15	15	20	21	20	19
Other Noncurrent Operating Assets	23	26	23	24	23	25	23	31
Total Liabilities & Shareholders' Equity	240	247	236	245	253	255	265	261
Total Liabilities	88	88	79	83	86	91	98	95
Total Current Liabilities	73	69	64	67	71	76	84	71
Accounts Payable	7.24	9.03	8.42	8.88	9.87	9.92	7.12	8.25
Accrued Expenses	55	46	45	46	48	50	57	51
Current Deferred Revenue	1.34	1.88	2.22	1.75	2.49	5.50	7.54	2.78
Current Deferred & Payable Income Tax Liabilities	4.68	7.21	3.91	6.52	6.54	5.77	7.60	4.97
Other Current Liabilities	4.51	5.06	3.96	4.04	4.29	4.63	4.60	4.37
Total Noncurrent Liabilities	15	19	16	16	15	15	14	23
Noncurrent Deferred & Payable Income Tax Liabilities	1.46	2.14	2.10	2.00	1.79	1.65	1.52	1.23
Noncurrent Employee Benefit Liabilities	0.69	0.80	0.89	0.89	0.94	1.04	1.11	1.28
Other Noncurrent Operating Liabilities	12	14	13	13	12	13	12	21
Total Equity & Noncontrolling Interests	152	160	156	163	167	164	167	167
Total Preferred & Common Equity	147	154	151	157	161	158	161	167
Total Common Equity	147	154	151	157	161	158	161	167
Common Stock	123	119	114	114	115	105	104	102
Retained Earnings	41	52	53	58	62	67	73	82
Accumulated Other Comprehensive Income / (Loss)	-17	-17	-17	-15	-16	-14	-16	-17

This table displays calculated financial ratios and metrics derived from Nature's Sunshine Products' official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-0.94%	-11.37%	5.07%	0.26%	6.66%	-0.71%	6.35%	15.29%	-4.99%	5.55%	2.03%
EBITDA Growth	-22.00%	-24.05%	-21.44%	-13.80%	10.28%	94.30%	28.72%	27.68%	-38.35%	36.36%	5.79%
EBIT Growth	-25.60%	-30.16%	-30.78%	-62.17%	2.16%	329.97%	47.52%	38.92%	-51.46%	28.54%	-6.71%
NOPAT Growth	21.59%	-39.10%	-93.93%	-913.32%	66.21%	455.38%	202.55%	52.29%	-98.21%	2,492.35%	-43.51%
Net Income Growth	-44.35%	39.35%	-95.06%	-2,146.96%	91.30%	676.46%	231.33%	31.58%	-98.18%	2,884.73%	-51.93%
EPS Growth	-47.66%	37.50%	-85.71%	-727.27%	94.20%	950.00%	214.71%	32.71%	-101.41%	3,950.00%	-48.05%
Operating Cash Flow Growth	-51.73%	-28.35%	-66.37%	207.99%	107.46%	-60.86%	340.71%	-8.10%	-97.95%	5,706.48%	-38.64%
Free Cash Flow Firm Growth	-153.54%	-66.94%	26.71%	200.20%	44.81%	-92.51%	2,234.66%	-16.09%	-139.64%	365.06%	-63.31%
Invested Capital Growth	76.82%	41.52%	13.04%	-16.38%	-21.06%	8.21%	-10.64%	11.40%	13.65%	-12.65%	-1.37%
Revenue Q/Q Growth	-0.15%	-2.01%	1.17%	1.28%	2.55%	-1.54%	2.68%	3.79%	-3.48%	1.41%	2.08%
EBITDA Q/Q Growth	-6.77%	7.53%	-27.81%	18.26%	7.62%	32.19%	-1.76%	7.54%	-1.64%	17.80%	1.69%
EBIT Q/Q Growth	-6.92%	7.67%	-36.89%	15.65%	41.55%	59.67%	-1.91%	10.56%	-2.95%	4.65%	-23.85%
NOPAT Q/Q Growth	-4.39%	30.45%	-93.17%	-74.13%	92.46%	108.06%	24.74%	39.25%	-96.09%	80.83%	-44.47%
Net Income Q/Q Growth	-37.71%	119.16%	-94.10%	-280.53%	92.49%	139.18%	30.98%	31.03%	-95.52%	79.29%	-56.08%
EPS Q/Q Growth	-40.43%	156.67%	-83.33%	-430.77%	95.06%	126.67%	30.49%	35.24%	-103.70%	87.80%	-54.55%
Operating Cash Flow Q/Q Growth	-32.11%	15.23%	-51.50%	64.67%	30.79%	-34.97%	26.03%	11.31%	-93.81%	17.11%	11.39%
Free Cash Flow Firm Q/Q Growth	-118.82%	2.85%	-39.56%	567.32%	537.09%	-72.71%	33.16%	19.95%	-303.61%	42.23%	20.98%
Invested Capital Q/Q Growth	5.20%	6.32%	-0.87%	-16.42%	-9.53%	-0.53%	-4.89%	2.07%	2.25%	1.22%	-9.21%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	75.00%	73.72%	73.34%	73.38%	73.77%	74.07%	73.71%	74.00%	71.05%	72.11%	71.46%
EBITDA Margin	6.45%	5.52%	4.13%	3.55%	3.67%	7.18%	8.70%	9.63%	6.25%	8.07%	8.37%
Operating Margin	5.20%	4.27%	2.94%	0.41%	1.47%	4.45%	5.58%	7.81%	3.85%	4.21%	4.42%
EBIT Margin	5.24%	4.13%	2.72%	1.03%	0.98%	4.26%	5.91%	7.12%	3.64%	4.43%	4.05%
Profit (Net Income) Margin	2.67%	4.21%	0.20%	-4.04%	-0.33%	1.91%	5.96%	6.80%	0.13%	3.69%	1.74%
Tax Burden Percent	51.54%	102.83%	7.28%	-428.83%	-37.56%	44.30%	100.60%	94.92%	3.61%	81.26%	42.83%
Interest Burden Percent	99.03%	99.03%	99.83%	91.77%	89.21%	101.42%	100.30%	100.68%	99.18%	102.45%	100.17%
Effective Tax Rate	-3.91%	13.10%	92.72%	528.83%	137.56%	55.70%	-0.60%	5.08%	96.39%	18.74%	57.17%
Return on Invested Capital (ROIC)	37.36%	14.75%	0.72%	-5.98%	-2.48%	9.60%	29.52%	45.06%	0.71%	18.59%	11.34%
ROIC Less NNEP Spread (ROIC-NNEP)	52.94%	11.60%	0.89%	23.52%	-4.55%	10.02%	27.60%	48.19%	0.77%	16.94%	12.19%
Return on Net Nonoperating Assets (RNNOA)	-28.99%	-4.45%	-0.21%	-4.98%	1.48%	-4.06%	-13.50%	-26.10%	-0.36%	-7.88%	-6.42%
Return on Equity (ROE)	8.37%	10.30%	0.50%	-10.96%	-1.00%	5.54%	16.02%	18.96%	0.36%	10.71%	4.92%
Cash Return on Invested Capital (CROIC)	-18.14%	-19.63%	-11.52%	11.85%	21.06%	1.72%	40.75%	34.28%	-12.07%	32.09%	12.72%
Operating Return on Assets (OROA)	9.69%	6.75%	4.57%	1.75%	1.85%	7.60%	9.84%	12.43%	6.28%	8.22%	7.50%
Return on Assets (ROA)	4.94%	6.87%	0.33%	-6.90%	-0.62%	3.41%	9.93%	11.88%	0.23%	6.85%	3.22%
Return on Common Equity (ROCE)	8.23%	10.04%	0.49%	-10.89%	-1.00%	5.54%	15.90%	18.66%	0.35%	10.37%	4.75%
Return on Equity Simple (ROE_SIMPLE)	7.83%	10.23%	0.51%	-11.58%	-1.00%	5.36%	14.77%	19.09%	0.38%	10.66%	5.08%
Net Operating Profit after Tax (NOPAT)	20	12	0.73	-5.95	-2.01	7.14	22	33	0.59	15	8.61
NOPAT Margin	5.40%	3.71%	0.21%	-1.74%	-0.55%	1.97%	5.61%	7.41%	0.14%	3.42%	1.89%
Net Nonoperating Expense Percent (NNEP)	-15.58%	3.15%	-0.17%	-29.50%	2.06%	-0.42%	1.92%	-3.13%	-0.05%	1.66%	-0.85%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-	9.55%	5.35%
Cost of Revenue to Revenue	25.00%	26.28%	26.66%	26.62%	26.23%	25.93%	26.29%	26.00%	28.95%	27.89%	28.54%
SG&A Expenses to Revenue	32.73%	33.17%	35.25%	37.90%	37.95%	35.54%	34.09%	34.70%	36.29%	37.51%	36.10%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	69.80%	69.44%	70.40%	72.98%	72.30%	69.61%	68.13%	66.19%	67.19%	67.90%	67.04%
Earnings before Interest and Taxes (EBIT)	19	13	9.28	3.51	3.59	15	23	32	15	20	18
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	24	18	14	12	13	26	33	43	26	36	38
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.94	1.27	2.01	1.73	1.23	1.27	1.79	2.31	1.12	2.14	1.74
Price to Tangible Book Value (P/TBV)	1.95	1.28	2.03	1.74	1.24	1.27	1.79	2.31	1.12	2.14	1.74
Price to Revenue (P/Rev)	0.66	0.52	0.77	0.60	0.41	0.45	0.72	0.82	0.38	0.74	0.60
Price to Earnings (P/E)	24.26	11.58	123.32	0.00	0.00	24.17	13.04	12.67	0.00	21.88	35.19
Dividend Yield	14.65%	4.37%	2.84%	3.66%	0.00%	0.00%	0.00%	5.41%	0.00%	0.00%	0.00%
Earnings Yield	4.12%	8.64%	0.81%	0.00%	0.00%	4.14%	7.67%	7.89%	0.00%	4.57%	2.84%
Enterprise Value to Invested Capital (EV/IC)	2.74	1.38	2.23	1.97	1.39	1.44	2.78	3.69	1.19	3.30	2.53
Enterprise Value to Revenue (EV/Rev)	0.51	0.41	0.71	0.52	0.27	0.31	0.50	0.64	0.25	0.57	0.42
Enterprise Value to EBITDA (EV/EBITDA)	7.86	7.38	17.10	14.65	7.41	4.29	5.73	6.65	3.95	7.01	5.02
Enterprise Value to EBIT (EV/EBIT)	9.67	9.87	25.96	50.68	27.65	7.24	8.44	9.00	6.78	12.79	10.38
Enterprise Value to NOPAT (EV/NOPAT)	9.38	10.98	329.45	0.00	0.00	15.62	8.89	8.64	177.04	16.55	22.18
Enterprise Value to Operating Cash Flow (EV/OCF)	13.09	13.02	70.51	16.91	4.54	13.06	5.10	8.22	146.55	6.12	7.55
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	15.11	5.81	87.33	6.44	11.36	0.00	9.59	19.78
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.02	0.07	0.11	0.01	0.01	0.03	0.02	0.01	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.11	0.00	0.00	0.02	0.01	0.00	0.00	0.00
Financial Leverage	-0.55	-0.38	-0.24	-0.21	-0.33	-0.40	-0.49	-0.54	-0.47	-0.47	-0.53
Leverage Ratio	1.69	1.50	1.51	1.59	1.62	1.62	1.61	1.60	1.58	1.56	1.53
Compound Leverage Factor	1.68	1.48	1.51	1.46	1.44	1.65	1.62	1.61	1.57	1.60	1.53
Debt to Total Capital	0.00%	1.94%	6.97%	10.26%	1.25%	1.16%	3.04%	1.66%	0.79%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	1.94%	6.97%	0.38%	1.25%	1.16%	1.55%	0.94%	0.79%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	9.88%	0.00%	0.00%	1.49%	0.72%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	2.93%	1.98%	0.90%	0.31%	0.05%	0.17%	1.14%	1.95%	2.79%	3.44%	3.53%
Common Equity to Total Capital	97.07%	96.08%	92.13%	89.43%	98.70%	98.67%	95.82%	96.39%	96.41%	96.56%	96.47%
Debt to EBITDA	0.00	0.15	0.70	1.13	0.11	0.06	0.15	0.06	0.04	0.00	0.00
Net Debt to EBITDA	0.00	-2.26	-1.71	-2.41	-3.67	-2.00	-2.63	-1.97	-2.26	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	1.09	0.00	0.00	0.07	0.03	0.00	0.00	0.00
Debt to NOPAT	0.00	0.22	13.56	-2.30	-0.76	0.21	0.23	0.08	2.00	0.00	0.00
Net Debt to NOPAT	0.00	-3.36	-33.01	4.91	24.43	-7.30	-4.08	-2.57	-101.34	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	-2.22	0.00	0.00	0.11	0.04	0.00	0.00	0.00
Altman Z-Score	4.80	3.84	4.24	3.74	3.41	3.45	4.21	4.97	3.86	4.94	4.98
Noncontrolling Interest Sharing Ratio	1.61%	2.46%	1.50%	0.67%	0.20%	0.12%	0.72%	1.58%	2.38%	3.14%	3.48%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.09	1.91	1.50	1.91	1.60	1.95	2.21	2.15	2.28	2.16	2.44
Quick Ratio	1.17	0.96	0.66	0.97	0.88	1.05	1.43	1.24	1.13	1.19	1.43
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-9.61	-16	-12	12	17	1.28	30	25	-9.92	26	9.65
Operating Cash Flow to CapEx	54.13%	52.38%	30.98%	211.33%	0.00%	167.48%	767.77%	523.41%	9.31%	393.45%	230.59%
Free Cash Flow to Firm to Interest Expense	-51.38	-123.39	-734.79	40.76	44.08	29.72	292.51	100.14	-39.85	381.19	66.10
Operating Cash Flow to Interest Expense	75.84	78.17	213.56	36.42	56.42	198.72	369.21	138.43	2.85	597.48	173.27
Operating Cash Flow Less CapEx to Interest Expense	-64.27	-71.05	-475.69	19.18	56.96	80.07	321.12	111.98	-27.78	445.62	98.13
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.85	1.63	1.68	1.71	1.88	1.78	1.67	1.75	1.73	1.86	1.85
Accounts Receivable Turnover	43.26	45.00	44.20	41.14	43.85	48.07	52.43	54.67	36.72	38.84	49.65
Inventory Turnover	2.22	2.16	2.11	1.99	2.22	2.12	2.15	2.13	1.90	1.84	2.05
Fixed Asset Turnover	8.79	5.41	4.81	4.80	5.48	5.86	6.77	8.44	8.70	9.77	10.74
Accounts Payable Turnover	16.80	14.74	15.62	19.13	20.29	19.52	18.60	14.27	15.22	17.42	15.42
Days Sales Outstanding (DSO)	8.44	8.11	8.26	8.87	8.32	7.59	6.96	6.68	9.94	9.40	7.35
Days Inventory Outstanding (DIO)	164.10	168.79	172.78	183.72	164.20	172.35	170.02	171.54	192.44	198.15	177.80
Days Payable Outstanding (DPO)	21.72	24.76	23.37	19.08	17.99	18.70	19.63	25.59	23.98	20.95	23.67
Cash Conversion Cycle (CCC)	150.81	152.14	157.66	173.50	154.53	161.24	157.35	152.63	178.39	186.60	161.48
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	68	96	108	91	71	77	69	77	87	76	75
Invested Capital Turnover	6.92	3.97	3.34	3.44	4.50	4.87	5.26	6.08	5.13	5.43	5.99
Increase / (Decrease) in Invested Capital	29	28	12	-18	-19	5.87	-8.23	7.88	11	-11	-1.04
Enterprise Value (EV)	186	132	241	178	99	112	192	284	104	252	191
Market Capitalization	243	170	264	207	148	163	278	366	159	330	271
Book Value per Share	$6.68	$7.18	$6.99	$6.31	$6.28	$6.68	$7.90	$8.01	$7.46	$8.08	$8.41
Tangible Book Value per Share	$6.64	$7.15	$6.94	$6.28	$6.24	$6.68	$7.90	$8.01	$7.46	$8.08	$8.41
Total Capital	129	139	142	133	122	131	162	164	148	160	161
Total Debt	0.00	2.70	9.92	14	1.53	1.52	4.92	2.72	1.17	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	13	0.00	0.00	2.42	1.17	0.00	0.00	0.00
Net Debt	-61	-40	-24	-29	-49	-52	-88	-84	-60	-83	-86
Capital Expenditures (CapEx)	26	19	11	4.98	-0.21	5.10	4.91	6.61	7.63	10	11
Debt-free, Cash-free Net Working Capital (DFCFNWC)	2.10	7.89	7.33	6.45	-8.97	2.65	-5.15	3.36	25	6.69	10
Debt-free Net Working Capital (DFNWC)	63	51	41	49	42	56	87	90	85	89	95
Net Working Capital (NWC)	63	48	31	49	40	55	84	88	84	89	95
Net Nonoperating Expense (NNE)	9.99	-1.60	0.06	7.87	-0.81	0.21	-1.35	2.70	0.04	-1.18	0.71
Net Nonoperating Obligations (NNO)	-61	-40	-24	-29	-49	-52	-88	-84	-60	-83	-86
Total Depreciation and Amortization (D&A)	4.41	4.53	4.81	8.63	9.81	11	11	11	11	16	20
Debt-free, Cash-free Net Working Capital to Revenue	0.57%	2.43%	2.15%	1.89%	-2.46%	0.73%	-1.34%	0.76%	5.94%	1.50%	2.24%
Debt-free Net Working Capital to Revenue	17.29%	15.73%	12.13%	14.43%	11.42%	15.54%	22.56%	20.16%	20.17%	20.00%	20.88%
Net Working Capital to Revenue	17.29%	14.90%	9.22%	14.28%	11.00%	15.12%	21.91%	19.82%	19.89%	20.00%	20.88%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.58	$0.79	$0.11	($0.69)	($0.04)	$0.35	$1.09	$1.45	($0.02)	$0.79	$0.41
Adjusted Weighted Average Basic Shares Outstanding	17.11M	18.66M	18.73M	18.88M	19.12M	19.31M	19.54M	19.86M	19.33M	19.07M	18.62M
Adjusted Diluted Earnings per Share	$0.56	$0.77	$0.11	($0.69)	($0.04)	$0.34	$1.07	$1.42	($0.02)	$0.77	$0.40
Adjusted Weighted Average Diluted Shares Outstanding	17.64M	19.18M	19.06M	18.88M	19.12M	19.66M	19.97M	20.33M	19.33M	19.47M	19.09M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	18.56M	18.71M	18.86M	19.02M	19.27M	19.47M	19.80M	19.45M	19.06M	18.82M	18.48M
Normalized Net Operating Profit after Tax (NOPAT)	13	12	7.03	0.97	3.75	11	15	33	11	15	14
Normalized NOPAT Margin	3.64%	3.71%	2.06%	0.28%	1.03%	3.12%	3.90%	7.41%	2.70%	3.42%	3.10%
Pre Tax Income Margin	5.19%	4.09%	2.72%	0.94%	0.88%	4.32%	5.92%	7.17%	3.61%	4.54%	4.06%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	102.68	103.15	580.13	12.15	9.27	358.67	223.06	126.42	61.61	285.78	125.99
NOPAT to Interest Expense	105.84	92.73	45.71	-20.58	-5.19	166.12	211.87	131.64	2.36	220.80	58.95
EBIT Less CapEx to Interest Expense	-37.43	-46.07	-109.13	-5.08	9.81	240.02	174.97	99.98	30.98	133.93	50.85
NOPAT Less CapEx to Interest Expense	-34.27	-56.50	-643.54	-37.81	-4.65	47.46	163.78	105.19	-28.27	68.95	-16.19
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	359.47%	54.85%	1,112.44%	-13.37%	0.00%	0.00%	0.00%	65.74%	0.00%	0.00%	0.00%
Augmented Payout Ratio	435.54%	103.51%	1,112.44%	-13.37%	0.00%	0.00%	0.00%	90.32%	2,467.45%	38.97%	112.25%

This table displays calculated financial ratios and metrics derived from Nature's Sunshine Products' official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
DEI Shares Outstanding	19,098,289.00	19,075,041.00	18,819,061.00	18,729,775.00	18,507,763.00	-	18,483,501.00	18,350,801.00	17,635,552.00	17,495,563.00
DEI Adjusted Shares Outstanding	19,098,289.00	19,075,041.00	18,819,061.00	18,729,775.00	18,507,763.00	-	18,483,501.00	18,350,801.00	17,635,552.00	17,495,563.00
DEI Earnings Per Adjusted Shares Outstanding	0.15	0.47	0.12	0.07	0.23	-	0.26	0.29	0.30	0.29
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	6.41%	6.02%	2.17%	-5.15%	3.07%	8.51%	2.03%	3.80%	11.97%	8.52%
EBITDA Growth	70.92%	23.26%	99.53%	10.60%	36.31%	-42.98%	32.83%	23.49%	13.86%	3.74%
EBIT Growth	79.60%	13.90%	173.07%	-30.86%	61.83%	-80.25%	50.41%	77.44%	21.53%	17.20%
NOPAT Growth	917.81%	393.35%	1,834.98%	-40.10%	-16.81%	-133.02%	71.43%	64.88%	65.26%	41.27%
Net Income Growth	1,471.00%	348.37%	98.72%	-44.42%	47.87%	-107.83%	96.14%	270.90%	19.13%	4.79%
EPS Growth	0.00%	360.00%	200.00%	-41.67%	53.33%	-104.35%	108.33%	300.00%	30.43%	16.00%
Operating Cash Flow Growth	121.77%	168.40%	-76.51%	-83.56%	-33.03%	26.94%	19.13%	232.57%	92.06%	-170.76%
Free Cash Flow Firm Growth	241.12%	298.12%	-84.23%	-138.68%	-131.98%	-106.96%	1,399.23%	284.20%	510.37%	-2.54%
Invested Capital Growth	-11.77%	-12.65%	2.40%	8.21%	9.96%	-1.37%	-4.28%	-6.36%	-15.63%	-2.03%
Revenue Q/Q Growth	-4.59%	-2.04%	1.89%	-0.40%	3.68%	3.13%	-4.19%	1.33%	11.84%	0.00%
EBITDA Q/Q Growth	4.93%	23.24%	-21.10%	8.40%	29.32%	-48.29%	83.80%	0.78%	19.23%	0.00%
EBIT Q/Q Growth	-17.56%	46.34%	-35.86%	-10.64%	92.95%	-82.05%	388.36%	5.42%	32.15%	0.00%
NOPAT Q/Q Growth	18.00%	86.36%	-64.47%	-23.33%	63.88%	-173.96%	284.48%	-26.26%	64.26%	0.00%
Net Income Q/Q Growth	17.37%	197.39%	-73.35%	-40.24%	212.23%	-115.76%	767.21%	13.00%	0.29%	0.00%
EPS Q/Q Growth	25.00%	206.67%	-73.91%	-41.67%	228.57%	-108.70%	1,350.00%	12.00%	7.14%	0.00%
Operating Cash Flow Q/Q Growth	80.93%	-33.18%	-77.18%	-40.41%	637.09%	26.67%	-78.59%	66.35%	325.67%	0.00%
Free Cash Flow Firm Q/Q Growth	13.76%	30.62%	-97.11%	-1,001.89%	5.96%	71.58%	721.92%	10.81%	109.51%	0.00%
Invested Capital Q/Q Growth	-5.89%	1.22%	8.92%	4.30%	-4.37%	-9.21%	5.71%	2.03%	-13.84%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	73.05%	71.90%	71.16%	71.36%	71.33%	71.96%	72.05%	71.72%	73.28%	73.22%
EBITDA Margin	8.29%	10.43%	8.07%	8.79%	10.96%	5.48%	10.51%	10.45%	11.14%	10.05%
Operating Margin	5.24%	5.24%	4.17%	5.10%	4.61%	3.85%	5.45%	3.72%	6.99%	7.77%
EBIT Margin	4.41%	6.59%	4.15%	3.72%	6.93%	1.20%	6.11%	6.36%	7.52%	6.60%
Profit (Net Income) Margin	2.83%	8.58%	2.24%	1.35%	4.05%	-0.62%	4.31%	4.81%	4.31%	4.16%
Tax Burden Percent	64.06%	121.97%	53.49%	33.64%	58.82%	-50.52%	68.70%	73.16%	57.23%	62.76%
Interest Burden Percent	100.00%	106.73%	101.11%	107.51%	99.51%	102.19%	102.66%	103.34%	100.26%	100.48%
Effective Tax Rate	35.94%	-21.97%	46.51%	66.36%	41.18%	150.52%	31.30%	26.84%	42.77%	37.24%
Return on Invested Capital (ROIC)	18.32%	34.73%	12.13%	9.07%	15.23%	-11.64%	20.99%	14.94%	24.81%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	19.21%	31.39%	12.10%	9.66%	13.26%	-13.50%	20.20%	11.79%	24.36%	0.00%
Return on Net Nonoperating Assets (RNNOA)	-8.68%	-14.61%	-5.61%	-4.38%	-6.58%	7.11%	-10.13%	-5.60%	-13.04%	0.00%
Return on Equity (ROE)	9.64%	20.12%	6.52%	4.69%	8.65%	-4.54%	10.86%	9.34%	11.78%	0.00%
Cash Return on Invested Capital (CROIC)	22.96%	32.09%	19.11%	11.97%	10.06%	12.72%	17.46%	20.96%	35.44%	2.05%
Operating Return on Assets (OROA)	8.36%	12.24%	7.71%	6.96%	12.71%	2.22%	11.17%	11.95%	13.98%	0.00%
Return on Assets (ROA)	5.35%	15.93%	4.17%	2.52%	7.44%	-1.15%	7.88%	9.03%	8.02%	0.00%
Return on Common Equity (ROCE)	9.34%	19.49%	6.31%	4.53%	8.34%	-4.38%	10.48%	9.00%	11.34%	0.00%
Return on Equity Simple (ROE_SIMPLE)	6.23%	0.00%	11.46%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	3.74	6.96	2.47	1.90	3.11	-2.30	4.24	3.13	5.14	5.99
NOPAT Margin	3.36%	6.39%	2.23%	1.72%	2.71%	-1.94%	3.74%	2.72%	4.00%	4.87%
Net Nonoperating Expense Percent (NNEP)	-0.90%	3.34%	0.02%	-0.59%	1.97%	1.86%	0.79%	3.15%	0.45%	-0.99%
Return On Investment Capital (ROIC_SIMPLE)	-	4.36%	1.53%	1.21%	1.91%	-1.43%	2.54%	1.91%	3.08%	3.59%
Cost of Revenue to Revenue	26.95%	28.10%	28.84%	28.64%	28.67%	28.04%	27.95%	28.28%	26.72%	26.78%
SG&A Expenses to Revenue	37.13%	36.59%	36.74%	34.88%	35.73%	36.98%	35.83%	38.05%	35.63%	35.43%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	67.81%	66.66%	66.99%	66.26%	66.72%	68.11%	66.60%	68.00%	66.29%	65.45%
Earnings before Interest and Taxes (EBIT)	4.91	7.18	4.60	4.11	7.94	1.42	6.93	7.30	9.65	8.12
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	9.22	11	8.96	9.71	13	6.48	12	12	14	12
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.15	2.14	2.54	1.87	1.61	1.74	1.44	1.72	1.71	2.51
Price to Tangible Book Value (P/TBV)	2.15	2.14	2.54	1.87	1.61	1.74	1.44	1.72	1.71	2.51
Price to Revenue (P/Rev)	0.72	0.74	0.87	0.64	0.57	0.60	0.51	0.59	0.58	0.00
Price to Earnings (P/E)	39.22	21.88	23.64	18.25	14.85	35.19	22.92	19.24	18.13	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	2.55%	4.57%	4.23%	5.48%	6.74%	2.84%	4.36%	5.20%	5.51%	0.00%
Enterprise Value to Invested Capital (EV/IC)	3.25	3.30	3.85	2.52	2.15	2.53	1.89	2.40	2.62	4.24
Enterprise Value to Revenue (EV/Rev)	0.56	0.57	0.71	0.49	0.40	0.42	0.33	0.42	0.39	0.00
Enterprise Value to EBITDA (EV/EBITDA)	8.03	7.01	9.19	5.57	4.19	5.02	3.67	4.51	4.07	0.00
Enterprise Value to EBIT (EV/EBIT)	13.00	12.79	14.14	10.50	7.49	10.38	7.26	8.16	7.15	0.00
Enterprise Value to NOPAT (EV/NOPAT)	29.09	16.55	18.11	13.17	11.52	22.18	14.10	16.12	12.96	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	6.96	6.12	9.39	7.96	7.86	7.55	5.85	6.78	4.87	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	13.25	9.59	20.36	21.86	22.38	19.78	10.57	11.07	6.76	205.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.45	-0.47	-0.46	-0.45	-0.50	-0.53	-0.50	-0.47	-0.54	-0.53
Leverage Ratio	1.58	1.56	1.57	1.54	1.54	1.53	1.53	1.53	1.55	1.54
Compound Leverage Factor	1.58	1.67	1.59	1.66	1.53	1.56	1.57	1.58	1.55	1.55
Debt to Total Capital	0.14%	0.00%	1.30%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.14%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	1.30%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	3.35%	3.44%	3.49%	3.70%	3.74%	3.53%	3.48%	3.67%	3.72%	0.00%
Common Equity to Total Capital	96.51%	96.56%	95.21%	96.30%	96.26%	96.47%	96.52%	96.33%	96.28%	100.00%
Debt to EBITDA	0.01	0.00	0.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	-2.51	0.00	-2.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.03	0.00	0.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	-9.08	0.00	-4.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	4.73	4.78	5.29	4.83	4.55	4.75	4.34	4.51	4.44	3.70
Noncontrolling Interest Sharing Ratio	3.10%	3.14%	3.32%	3.46%	3.56%	3.48%	3.51%	3.68%	3.73%	1.74%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.19	2.16	2.33	2.39	2.44	2.44	2.41	2.27	2.22	2.50
Quick Ratio	1.17	1.19	1.27	1.26	1.34	1.43	1.38	1.24	1.32	1.40
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	14	18	0.52	-4.69	-4.41	-1.25	7.80	8.65	18	7.60
Operating Cash Flow to CapEx	320.41%	769.07%	59.37%	38.94%	554.09%	555.08%	235.05%	321.48%	1,097.68%	-74.44%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	43.37	-45.57	-169.77	0.00	371.54	360.24	696.70	217.27
Operating Cash Flow to Interest Expense	0.00	0.00	182.50	12.67	369.96	0.00	124.24	180.83	710.54	-52.74
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	-124.92	-19.86	303.19	0.00	71.38	124.58	645.81	-123.60
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.90	1.86	1.86	1.87	1.83	1.85	1.83	1.88	1.86	0.00
Accounts Receivable Turnover	45.11	38.84	44.40	37.18	42.62	49.65	43.27	37.90	35.80	0.00
Inventory Turnover	1.82	1.84	1.91	1.94	1.98	2.05	2.03	1.98	2.03	0.00
Fixed Asset Turnover	9.38	9.77	9.80	9.79	10.08	10.74	11.01	11.41	12.49	0.00
Accounts Payable Turnover	16.61	17.42	13.99	16.18	15.78	15.42	13.69	14.18	16.45	0.00
Days Sales Outstanding (DSO)	8.09	9.40	8.22	9.82	8.56	7.35	8.44	9.63	10.20	0.00
Days Inventory Outstanding (DIO)	200.01	198.15	190.80	188.24	184.56	177.80	180.06	184.64	179.86	0.00
Days Payable Outstanding (DPO)	21.98	20.95	26.09	22.56	23.13	23.67	26.67	25.74	22.19	0.00
Cash Conversion Cycle (CCC)	186.12	186.60	172.92	175.49	170.00	161.48	161.83	168.54	167.87	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	75	76	83	87	83	75	80	81	70	78
Invested Capital Turnover	5.45	5.43	5.44	5.29	5.62	5.99	5.61	5.48	6.20	0.00
Increase / (Decrease) in Invested Capital	-10	-11	1.95	6.59	7.52	-1.04	-3.56	-5.52	-13	-1.61
Enterprise Value (EV)	245	252	320	218	179	191	150	195	183	331
Market Capitalization	316	330	391	282	252	271	232	271	274	420
Book Value per Share	$7.69	$8.08	$8.19	$8.04	$8.46	$8.41	$8.73	$8.59	$9.10	$9.53
Tangible Book Value per Share	$7.69	$8.08	$8.19	$8.04	$8.46	$8.41	$8.73	$8.59	$9.10	$9.53
Total Capital	152	160	162	156	163	161	167	164	167	167
Total Debt	0.22	0.00	2.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	2.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-77	-83	-76	-70	-80	-86	-87	-82	-97	-89
Capital Expenditures (CapEx)	4.48	1.25	3.69	3.35	1.74	2.20	1.11	1.35	1.68	2.48
Debt-free, Cash-free Net Working Capital (DFCFNWC)	11	6.69	14	20	18	10	14	15	6.88	20
Debt-free Net Working Capital (DFNWC)	87	89	91	88	96	95	100	96	102	107
Net Working Capital (NWC)	87	89	91	88	96	95	100	96	102	107
Net Nonoperating Expense (NNE)	0.59	-2.38	-0.02	0.41	-1.54	-1.57	-0.64	-2.39	-0.40	0.87
Net Nonoperating Obligations (NNO)	-77	-83	-76	-70	-80	-86	-87	-82	-97	-89
Total Depreciation and Amortization (D&A)	4.31	4.18	4.36	5.60	4.62	5.06	4.98	4.70	4.66	4.23
Debt-free, Cash-free Net Working Capital to Revenue	2.53%	1.50%	3.02%	4.46%	3.97%	2.24%	2.97%	3.18%	1.45%	0.00%
Debt-free Net Working Capital to Revenue	19.84%	20.00%	20.39%	20.01%	21.65%	20.88%	21.91%	20.83%	21.59%	0.00%
Net Working Capital to Revenue	19.79%	20.00%	20.39%	20.01%	21.65%	20.88%	21.91%	20.83%	21.59%	0.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.15	$0.46	$0.12	$0.07	$0.23	($0.01)	$0.26	$0.29	$0.30	$0.29
Adjusted Weighted Average Basic Shares Outstanding	19.13M	19.07M	18.83M	18.65M	18.51M	18.62M	18.49M	18.41M	17.64M	17.52M
Adjusted Diluted Earnings per Share	$0.15	$0.46	$0.12	$0.07	$0.23	($0.02)	$0.25	$0.28	$0.30	$0.29
Adjusted Weighted Average Diluted Shares Outstanding	19.49M	19.47M	19.22M	19.12M	18.89M	19.09M	18.85M	18.97M	18.03M	17.93M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	19.08M	18.82M	18.73M	18.51M	18.48M	18.48M	18.35M	17.64M	17.50M	17.58M
Normalized Net Operating Profit after Tax (NOPAT)	3.74	4.00	2.47	3.95	3.11	3.19	4.24	3.13	5.14	5.99
Normalized NOPAT Margin	3.36%	3.67%	2.23%	3.57%	2.71%	2.69%	3.74%	2.72%	4.00%	4.87%
Pre Tax Income Margin	4.41%	7.03%	4.19%	4.00%	6.89%	1.23%	6.28%	6.57%	7.54%	6.64%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	383.67	39.94	305.31	0.00	329.76	304.17	371.04	231.89
NOPAT to Interest Expense	0.00	0.00	206.12	18.41	119.54	0.00	201.92	130.28	197.54	171.15
EBIT Less CapEx to Interest Expense	0.00	0.00	76.25	7.41	238.54	0.00	276.90	247.92	306.31	161.03
NOPAT Less CapEx to Interest Expense	0.00	0.00	-101.30	-14.12	52.77	0.00	149.06	74.03	132.81	100.30
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	31.17%	38.97%	42.04%	80.19%	70.15%	112.25%	72.79%	94.21%	97.32%	0.00%

Financials Breakdown Chart

Key Financial Trends

Nature's Sunshine Products (NASDAQ: NATR) showed a mixed start to 2026, with healthy revenue and profit but a sharp deterioration in operating cash flow. For Q1 2026, revenue rose to $122.9 million from $113.2 million in Q1 2025, and net income climbed to $5.1 million from $4.9 million. However, cash from operations was negative $1.8 million, compared with positive $2.6 million a year earlier, driven by a large swing in working capital.

Top-line growth remains intact. Revenue increased year over year in each of the last four reported quarters shown here, including Q1 2026 (+8.5% vs. Q1 2025) and Q3 2025 (+12.2% vs. Q3 2024). That suggests the business has continued demand momentum rather than a one-quarter anomaly.

Q1 2026 revenue grew 8.5% year over year to $122.9 million, showing continued sales momentum.
Gross profit rose to $90.0 million in Q1 2026, and gross margin improved modestly versus the prior year period.
Net income increased to $5.1 million in Q1 2026 from $4.9 million in Q1 2025.
The balance sheet remains solid, with $87.6 million in cash and equivalents and $166.9 million in total equity at March 31, 2026.
Debt appears manageable overall, and the company continued to reduce/reshape financing activity rather than heavily lever up the business.
Revenue has grown steadily across the last several quarters, but the pace has not been especially fast and profitability remains modest relative to sales.
The company continues to spend on capital expenditures, with $2.5 million of PP&E purchases in Q1 2026, suggesting ongoing investment in operations.
SG&A costs remain high in absolute terms, at $43.5 million in Q1 2026, which keeps operating margins thin.
Operating cash flow turned negative in Q1 2026 at $(1.8) million, down from positive $2.6 million in Q1 2025.
Working capital was a major drag in Q1 2026, with changes in operating assets and liabilities reducing cash flow by $17.3 million.

Profitability is better than it was a year ago, but not dramatically so. Q1 2026 operating income was $9.5 million, up from $6.2 million in Q1 2025, helped by stronger gross profit and better leverage in operating results. Still, other operating expenses remained substantial at $36.9 million, which limits margin expansion.

The biggest concern is cash generation. Despite reported earnings, the company burned cash from operations in Q1 2026. That’s a notable reversal from the prior-year quarter and a reminder that earnings quality can be uneven when working capital swings are large. For a consumer/health products company like NATR, investors should watch inventory, receivables, and accrued liabilities closely.

The balance sheet looks stable, but there are some signs of pressure. Cash fell from $95.6 million at Q3 2025 to $87.6 million at Q1 2026, while total liabilities declined to $94.5 million from $98.1 million. Equity also increased to $166.9 million, which is constructive. However, the quarter’s cash burn means the company may need stronger operating cash conversion to maintain this cushion over time.

Bottom line: Nature's Sunshine Products is still growing revenue and earning money, and its balance sheet remains relatively healthy. But the weak Q1 2026 operating cash flow and large working-capital drag are the main issues investors should monitor going forward.

07/06/26 08:09 AM ETAI Generated. May Contain Errors.

Nature's Sunshine Products Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Nature's Sunshine Products' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

Nature's Sunshine Products' net income appears to be on an upward trend, with a most recent value of $7.89 million in 2024, falling from $9.80 million in 2014. The previous period was $16.42 million in 2023. See Nature's Sunshine Products' forecast for analyst expectations on what's next for the company.

Nature's Sunshine Products' total operating income in 2024 was $20.10 million, based on the following breakdown:

Total Gross Profit: $324.69 million
Total Operating Expenses: $304.59 million

Over the last 10 years, Nature's Sunshine Products' total revenue changed from $366.37 million in 2014 to $454.36 million in 2024, a change of 24.0%.

Nature's Sunshine Products' total liabilities were at $99.59 million at the end of 2025, a 24.7% increase from 2024, and a 55.0% increase since 2015.

In the past 10 years, Nature's Sunshine Products' cash and equivalents has ranged from $32.28 million in 2016 to $93.89 million in 2025, and is currently $93.89 million as of their latest financial filing in 2025.

Over the last 10 years, Nature's Sunshine Products' book value per share changed from 6.68 in 2014 to 8.41 in 2024, a change of 25.9%.

Related Companies

Financial statements for NASDAQ:NATR last updated on 7/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Nature's Sunshine Products (NATR) Financials

Financials Breakdown Chart

Key Financial Trends

Nature's Sunshine Products Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Nature's Sunshine Products (NATR) Financials

Annual Income Statements for Nature's Sunshine Products

Quarterly Income Statements for Nature's Sunshine Products

Annual Cash Flow Statements for Nature's Sunshine Products

Quarterly Cash Flow Statements for Nature's Sunshine Products

Annual Balance Sheets for Nature's Sunshine Products

Quarterly Balance Sheets for Nature's Sunshine Products

Annual Metrics And Ratios for Nature's Sunshine Products

Quarterly Metrics And Ratios for Nature's Sunshine Products

Financials Breakdown Chart

Key Financial Trends

Nature's Sunshine Products Financials - Frequently Asked Questions

When does Nature's Sunshine Products' fiscal year end?

How has Nature's Sunshine Products' net income changed over the last 10 years?

What is Nature's Sunshine Products' operating income?

How has Nature's Sunshine Products' revenue changed over the last 10 years?

How much debt does Nature's Sunshine Products have?

How much cash does Nature's Sunshine Products have?

How has Nature's Sunshine Products' book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools